AEROLONE Drug Patent Profile
✉ Email this page to a colleague
When do Aerolone patents expire, and when can generic versions of Aerolone launch?
Aerolone is a drug marketed by Lilly and is included in one NDA.
The generic ingredient in AEROLONE is isoproterenol hydrochloride. There are seventeen drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the isoproterenol hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Aerolone
A generic version of AEROLONE was approved as isoproterenol hydrochloride by NEXUS on August 2nd, 2017.
US Patents and Regulatory Information for AEROLONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lilly | AEROLONE | isoproterenol hydrochloride | SOLUTION;INHALATION | 007245-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Get Started Free | ⤷ Get Started Free | ⤷ Get Started Free | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
